Craig Hallum Increases Bioventus (NYSE:BVS) Price Target to $17.00

Bioventus (NYSE:BVS – Get Free Report) had its price objective boosted by equities research analysts at Craig Hallum from $12.00 to $17.00 in a research report issued on Friday, Benzinga reports. The brokerage presently has a “buy” rating on the stock. Craig Hallum’s price objective suggests a potential upside of 46.05% from the stock’s previous […]

Leave a Reply

Your email address will not be published.

Previous post Citigroup Begins Coverage on Archrock (NYSE:AROC)
Next post Carvana’s (CVNA) In-Line Rating Reaffirmed at Evercore ISI